0001127602-24-014115.txt : 20240503 0001127602-24-014115.hdr.sgml : 20240503 20240503160642 ACCESSION NUMBER: 0001127602-24-014115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240502 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valente Nancy CENTRAL INDEX KEY: 0001891344 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36182 FILM NUMBER: 24913051 MAIL ADDRESS: STREET 1: C/O MYOVANT SCIENCES INC. STREET 2: 2000 SIERRA POINT PARKWAY, 9TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xencor Inc CENTRAL INDEX KEY: 0001326732 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 201622502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 BUSINESS PHONE: 626-305-5900 MAIL ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-02 0001326732 Xencor Inc XNCR 0001891344 Valente Nancy C/O XENCOR, INC. 465 N HALSTEAD STREET, SUITE 200 PASADENA CA 91107 1 EVP, Chief Development Officer 0 Common Stock 2024-05-02 4 S 0 4745 23.5768 D 55115 D Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 13,098 restricted stock units. /s/ Celia E. Eckert, Attorney-in-Fact 2024-05-03